Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

BACKGROUND: Preoperative imatinib mesylate (IM) treatment has not yet been standardized. Here, we aim to further explore such therapy on patients with gastrointestinal stromal tumors (GIST) retrospectively. METHODS: Patients experiencing preoperative IM were identified from January 2009 to February...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Sumin, Yin, Yuan, Shen, Chaoyong, Chen, Jiaju, Yin, Xiaonan, Zhang, Bo, Yao, Yuqin, Yang, Jinliang, Chen, Zhixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387273/
https://www.ncbi.nlm.nih.gov/pubmed/28399894
http://dx.doi.org/10.1186/s12957-017-1143-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387273/
https://www.ncbi.nlm.nih.gov/pubmed/28399894
http://dx.doi.org/10.1186/s12957-017-1143-2

Ejemplares similares